Business Context and Reporting Period
This Form 6-K filing covers the month of October 2011 for Prana Biotechnology Limited (ASX: PBT), a foreign private issuer. The document reports the results of the company's 2011 General Meeting held on October 7, 2011. Note: The metadata provided lists "Alterity Therapeutics Ltd," but the filing text explicitly identifies the registrant as Prana Biotechnology Limited.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding shareholder voting results and does not contain financial statements.
Material Changes
No material financial changes are reported in this filing. The document details the outcome of shareholder resolutions passed at the General Meeting.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It confirms that all resolutions contained in the Notice of Meeting were unanimously carried on a show of hands. Specific voting results included:
- Election of Mr. Lawrence Gozlan as Director: 45,487,397 votes For; 1,129,666 votes Against; 717,760 Abstain; 3,003,231 Discretionary (Total: 50,338,054).
- Replacement of Previous Shareholder Approval for Share Place: 44,031,393 votes For; 2,480,670 votes Against; 822,760 Abstain; 3,003,231 Discretionary (Total: 50,338,054).
The Chairman voted undirected proxies in his control in favor of all resolutions.
Investor Verification Checklist
- Verify the correct registrant name is Prana Biotechnology Limited, not Alterity Therapeutics Ltd.
- Confirm the successful election of Mr. Lawrence Gozlan to the Board of Directors.
- Review the specific terms of the "Share Place" approval resolution to understand the scope of the shareholder authorization.
- Check subsequent filings for financial data, as this 6-K contains no financial metrics.